Cryptosporidium, sometimes informally called crypto, is a genus of apicomplexan parasitic alveoli that can cause respiratory and gastrointestinal disease (cryptosporidiosis). Cryptosporidium has three developmental stages: meronts, gamonts and oocysts. The Cryptosporidium spore phase (oocyst) can survive for lengthy periods outside a host. It can also resist many common disinfectants, notably chlorine-based disinfectants
Treating gastrointestinal infections in humans with rehydrating fluids, replacing electrolytes, and managing any pain. Since January 2015, nitazoxanide has been the only drug approved for the treatment of cryptosporidiosis in immunocompetent hosts. A zinc supplement can improve symptoms, especially zinc deficiency in recurrent or persistent infections or other people at risk. Cryptosporidium oocysts have a diameter of 4 to 6 μm and have a partial color resistant to acids. They must be differentiated from other organisms that are partially resistant to acids, in particular Cyclospora cayetanensis.
Cryptosporidium Causes Cryptosporidiosis, Unemployment which can be present in immunocompetent hosts with or without diarrhea. Other apicomplexic pathogens include the malaria parasite Plasmodium and the toxoplasmosis parasite Toxoplasma. Unlike Plasmodium, which is transmitted via a vector mosquito, Cryptosporidium does not use a single vector insect and is capable of completing its entire life cycle within a single host, which leads to cystic stages. to a new host
Scientific Tracks Abstracts: Applied Microbiology: Open Access
Scientific Tracks Abstracts: Journal of Antivirals & Antiretrovirals